I'm bullish on NERV and have played it for short pops before, but at this ATL level it's looking really attractive for a longer term play. Why? institutional ownership.
Per https://elite.finviz.com/quote.ashx?t=nerv
NERV has a 41.21M Float and 42.72M Outstanding Shares, relatively low!
Insiders own 3.43%
Institutions own 65%
Short Interest % Float - 4.41%
190 total, 186 long only, 0 short only, 4 long/short - change of 0.00% MRQ
The 52 Week Range is 1.25 - 4.11, so plenty of potential for 100%, 200%, 300% plays with enough paytience.
Also, per most recent 8-K, the meeting downgrade "has not changed its previously announced projected timeline for submission of the NDA in the first half of 2022."
The company will be announcing their earnings on November 8, 2021 which will either create a quick pop for a daytrading opportunity, or there will be another opportunity to buy cheapies for the longer term swing.
Besides the earnings, the other catalysts for trading opportunities would be any trial updates, presentations at nuerology conferences, schizophrenia sympathy plays, bio sector heating up.
Per https://elite.finviz.com/quote.ashx?t=nerv
NERV has a 41.21M Float and 42.72M Outstanding Shares, relatively low!
Insiders own 3.43%
Institutions own 65%
Short Interest % Float - 4.41%
190 total, 186 long only, 0 short only, 4 long/short - change of 0.00% MRQ
The 52 Week Range is 1.25 - 4.11, so plenty of potential for 100%, 200%, 300% plays with enough paytience.
Also, per most recent 8-K, the meeting downgrade "has not changed its previously announced projected timeline for submission of the NDA in the first half of 2022."
The company will be announcing their earnings on November 8, 2021 which will either create a quick pop for a daytrading opportunity, or there will be another opportunity to buy cheapies for the longer term swing.
Besides the earnings, the other catalysts for trading opportunities would be any trial updates, presentations at nuerology conferences, schizophrenia sympathy plays, bio sector heating up.